Table 3.
Distribution of clinical dengue virus sequencing datasets
Drug | Placebo | Total | |
---|---|---|---|
DENV1 | 8 (19) | 11 (22) | 19 (41) |
DENV2 | 5 (11) | 2 (4) | 7 (15) |
DENV3 | 2 (5) | 2 (4) | 4 (9) |
Total | 15 (35) | 15 (30) | 30 (65) |
The samples analyzed here were collected as part of a drug-trial study for the nucleoside-analog Balapiravir (31). Numbers in parentheses report the total number of samples sequenced, while un-parenthesized numbers report the number of pairs (a pre- and a post-dose sample) that were sequenced.